0001554795-13-000649.txt : 20131101
0001554795-13-000649.hdr.sgml : 20131101
20131101164016
ACCESSION NUMBER: 0001554795-13-000649
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131031
FILED AS OF DATE: 20131101
DATE AS OF CHANGE: 20131101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLETCHER MARK
CENTRAL INDEX KEY: 0001229529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 131186477
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQUARE
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J2G2
4
1
gnbt103113form4fletcher.xml
FORM 4
X0306
4
2013-10-31
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001229529
FLETCHER MARK
555 RICHMOND ST. W, SUITE 604
TORONTO
A6
M5V3B1
ONTARIO, CANADA
1
1
0
0
President and CEO
Common Stock Purchase Option (right to buy)
0.001
2013-10-31
4
A
0
2254640
0
A
2014-01-01
2018-10-31
Common Stock
2254640
2254640
D
On October 31, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 2,254,640 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective October 31, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan (1,854,640 options) and the 2001 stock plan (400,000 options).
/s/ Mark A. Fletcher
2013-11-01